Jim Simons I Mab Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in I Mab stock. As of the latest transaction made, Renaissance Technologies LLC holds 63,800 shares of IMAB stock, worth $95,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,800

Previous 63,800 -0.0%

Holding current value

$95,700

Previous $121,000 1.65%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.18 - $3.06 $215,359 - $558,474	-182,508 Reduced 74.1%	63,800 $84,000
Q2 2023 Aug 11, 2023	BUY	$2.95 - $3.85 $113,575 - $148,225	38,500 Added 18.53%	246,308 $736,000
Q1 2023 May 12, 2023	BUY	$3.08 - $7.39 $494,980 - $1.19 Million	160,708 Added 341.21%	207,808 $719,000
Q4 2022 Feb 13, 2023	SELL	$3.22 - $4.86 $367,080 - $554,040	-114,000 Reduced 70.76%	47,100 $197,000
Q3 2022 Nov 14, 2022	BUY	$4.01 - $12.34 $646,011 - $1.99 Million	161,100 New	161,100 $646,000

Q2 2022 Aug 12, 2022	SELL	$8.27 - $18.43 $1.14 Million - $2.53 Million	-137,400 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.54 - $46.93 $1.1 Million - $4.1 Million	-87,400 Reduced 38.88%	137,400 $2.23 Million
Q4 2021 Feb 11, 2022	BUY	$45.28 - $74.5 $194,704 - $320,350	4,300 Added 1.95%	224,800 $10.7 Million
Q3 2021 Nov 12, 2021	BUY	$57.18 - $84.43 $2.54 Million - $3.76 Million	44,500 Added 25.28%	220,500 $16 Million
Q2 2021 Aug 13, 2021	BUY	$47.86 - $83.95 $3.44 Million - $6.04 Million	71,900 Added 69.07%	176,000 $14.8 Million
Q1 2021 May 13, 2021	SELL	$44.38 - $63.97 $1.61 Million - $2.32 Million	-36,300 Reduced 25.85%	104,100 $5.05 Million
Q4 2020 Feb 10, 2021	BUY	$32.94 - $47.15 $1 Million - $1.43 Million	30,400 Added 27.64%	140,400 $6.62 Million
Q3 2020 Nov 13, 2020	BUY	$27.46 - $47.03 $2.38 Million - $4.07 Million	86,500 Added 368.09%	110,000 $5.17 Million
Q2 2020 Aug 13, 2020	BUY	$13.0 - $31.0 $305,500 - $728,500	23,500 New	23,500 $703,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

16M

Call Options Held

11.9K

Put Options Held

3.5K

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $125M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account